Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 1
A Phase 1 Pilot Safety and Feasibility Study of Autologous Engineered Urethral
This is a Phase I clinical study to determine the safety and efficacy of using autologous, engineered urethral constructs for the treatment of urethral strictu…
Urologic DiseasesMale Urogenital DiseasesUrethral Stricture+1 more
Estimated
~$10 – $6,250
Wake Forest University Health SciencesNCT03258658
Phase 4
Usefulness of Tumor Heterogeneity Assessment in Patients With MCRPC Undergoing Radioligand Therapy With 177LU-PSMA-617 Using Serial 18F-DCFPYL, 18F-FDG and 18F-Fluciclovine PET/CT Predicting Clinical Outcome
This a single-center, prospective, exploratory study. Patients with metastatic castration-resistant prostate cancer (mCRPC) scheduled to undergo Lutetium label…
Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMetastatic Prostate Cancer+8 more
Estimated
~$10 – $7,500
VA Greater Los Angeles Healthcare SystemNCT06706921
Phase 1
A Phase 1/2, Open-Label, Randomized, Dose Finding and Dose Expansion Study of Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisib in combi…
mCRPC (Metastatic Castration-resistant Prostate Cancer)Genital Diseases, MaleUrogenital Diseases, Male+3 more
Estimated
~$10 – $8,750
Celcuity IncNCT06190899
Phase 1
Phase 1 Pilot Study of Bioengineered Penile Tissue Constructs in Subjects With Irreversibly Damaged Penile Corpora
The primary objective of this clinical trial is to evaluate the safety of autologous engineered corpora cavernosa + albuginea constructs for treatment of compl…
Urologic DiseasesMale Urogenital DiseasesPenile Diseases+3 more
Estimated
~$10 – $6,250
Wake Forest University Health SciencesNCT03463239